The D&B EMMA (Entry Market Medication Alert) Score
The D&B EMMA (Entry Market Medication Alert) Score has been developed to better equip customers to understand the likelihood of a business being problematic in paying its debts within the next 12 months and eventually going out of business.
The Score is the result of risk assessment processes that evaluate the financial status, payment history and commercial characteristics of businesses.
The EMMA Score is a predictive score reserved for new markets where data availability does not yet support a Failure or Delinquency Score.
The D&B EMMA Score is based on a scale of 1 to 10, where 1 represents the lowest risk and 10 the highest risk of default.
The DUNSRight™ Process